About Us

We believe in people and their potential. We envision a world where everyone is operating at peak mental performance, free from the stresses and imbalances that hold us back.

MISSION

Empowering human potential. 

Using evidence-informed research, we are on a mission to unlock human performance and empower people to achieve their full potential. Through end to end research, extraction, formulation and delivery, we aspire to define and standardize the future of modern medicine.

OUR STORY

HAVN Life is a part of a global community taking an active part in supporting research addressing mental health disorders. Working with Veterans and thought leaders in the military, HAVN Life is developing innovative formulations to support clinical trials addressing PTSD recovery and other trauma related disorders.

We are focused on standardizing extraction of psychoactive compounds, the development of natural health products, and developing innovative mental health treatment to support brain health and enhance the capabilities of the mind.

With an extensive team of industry leaders with 20+ years of experience in this space, HAVN Life is formulating the next generation of medicine using psychedelic compounds. 

Our Values

At HAVN Life, we are dedicated to innovation, diversity and implementing the highest standards of the scientific method.

We have a deep-seated drive to help others and share our knowledge. With a range of standardized, quality-controlled formulated products, HAVN Life will provide cutting edge technology and intellectual property for mental health and human performance with a strong focus on psychoactive natural healthcare products.

Our Team

Collaboration across disciplines

Creating positive patient experiences and mental health outcomes

Tim Moore

CEO and Chair

Former CEO of Green Growth Brands. Led the Company to ~$1 Billion market cap. Former President of Clorox Canada and COO of Synnex Canada.. Managing Director at Brita North America group, responsible for building a new business organization across B2B and B2C divisions.

Dr. Ivan Casselman

Director

Executive-level cannabis advisory. Formerly on the management team of NextLeaf during IPO Extensive nutraceutical formulation, with products available in legal cannabis markets in North America. Research spanning human use of psychedelics (ethnobotany and ethnopharmacy) to the study of plant genetics and analytical chemistry.

Alexzander Samuelsson

Director

Lead chemist of a publicly traded extraction company. Developed intellectual property and patented methods in the extraction of cannabis oils. Strategic support for startups in their implementation of capital projects in Canada, Europe, Central and South Asia through his consulting company Development Catalyst.

Jenna Pozar

Chief Operations Officer

18 years of NHP marketing and logistics experience, including Jamieson Wellness and Body Plus. Responsible for the growth and planning for 200+ retail store accounts and three national chains, with a portfolio of eight natural health and performance brands.

Path To Market

regulated Route To Market

.  

.
.
.
.
.

Direct To Consumers

Natural Health Products

  .  .  

.
.
.
.
.

Contract Manufacturer
(White Label)

Natural Health Products

.
.
.
.
.

Direct To Consumers

Contract Manufacturer
(White Label)

ReSTRICTED COMPOUND Route To Market

.  

.
.
.
.
.

Supply Academic Research
(Dealers License)

Psychedelic Extraction and Supply

  

.
.
.
.
.

Formulate Microdosing Therapies
(Pre-Clinical Trials)

Psychedelic Extraction and Supply

.
.
.
.
.

Supply Academic Research
(Dealers License)

Formulate Microdosing Therapies
(Pre-Clinical Trials)

Mushroom Market

Demand for mushrooms is growing. The market for mushrooms such as Lion’s Mane, Cordyceps, Reishi, and Chaga is rising. These mushrooms have numerous benefits that we are still discovering today. Mushrooms are an extremely beneficial and nutritious functional food that will continue to be a key player in the global functional food market. The market is set to reach a value of $34.3 Billion USD by 2024.

Growing Mushroom Market

Global Revenue in 2016 – 2024

The global functional food market is expected to reach $34.3 Billion USD by 2024, registering a CAGR of 8.04% during the forecast period (2019-2024)

The market studied is expected to experience huge demand for Reishi and Cordyceps and this is why HAVN Life has decided to pursue formulations with these mushrooms.

Roadmap

2020

HAVN logo
HAVN Labs

One of the first companies to receive permission from Health Canada to work with psilocybin

2020

2020

havn logo
HAVN Labs

Finalize Pre-Clinical Protocols for Compound Extraction and Supply

2020

2021

havn logo
HAVN Retail

Manufacture & Distribute at Scale

2021

2021

havn logo
HAVN Labs

Licensed Dealer Approval

2021

2021

havn logo
HAVN Labs

Supply Clinical Trials with GMP Certified Psychedelic Compounds

2021

2021

havn logo
HAVN Labs

Formulate Psychedelic Therapies for Clinical Trials

2021

2022+

havn logo
HAVN Retail

Expansion of Distribution Channels

2022+

2022+

havn logo
HAVN Labs

Publish Analytical Method Results

2022+
Scroll to Top